The level of cellular immunity was higher for participants who received two doses of mRNA-based vaccines, and particularly the schedule ChAdOx1/ChAdOx1 among COVID-19 naïve individuals showed the lowest level of IFN-γ production after stimulation. The gene discussed is IFNG; the disease is COVID-19.